⌘K

Mirae Asset Capital Life Science logo

Mirae Asset Capital Life Science

Crunchbase
Pitchbook
Crunchbase

Deals on record

4

Common Fundraising Type

Series A

Attovia Therapeutics logo
Attovia Therapeutics

Biopharma • Immune-mediated diseases

Deep Track Capital logo
Vida Ventures logo
Sanofi Ventures logo
Mirae Asset Capital Life Science logo

Attovia Therapeutics is a biopharmaceutical company developing treatments for immune-mediated diseases using its proprietary ATTOBODY platform.

Series C
$90M
04/16/2025
Article
VESSL AI logo
VESSL AI

MLOps • GPU cost reduction

Woori Venture Investment logo
Ubiquitous Investment logo
SJ Investment Partners logo
Shinhan Venture Investment logo

VESSL AI is a South Korean MLOps platform that reduces GPU costs and streamlines AI model training, deployment, and operation through a hybrid infrastructure and multi-cloud strategy.

Series A
$12M
10/07/2024
Article
Mediwhale logo
Mediwhale

AI • Health diagnostics

Korea Development Bank logo
Woori Venture Partners logo
Mirae Asset Securities logo
IMM Investment logo

Mediwhale is an AI-powered health diagnostics company that uses retina scans to predict cardiovascular disease risk.

Series A
$12M
09/25/2024
Article
Candid Therapeutics logo
Candid Therapeutics

Biotechnology • Autoimmune therapies

Venrock Healthcare Capital Partners logo
Vida Ventures logo
TCGX logo
Third Rock Ventures logo

Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.

Equity
$370M
09/09/2024
Article